Abstract:STUDY QUESTION: Does bone morphogenetic protein 2 (BMP2) regulate connexin43 (Cx43) and modulate cell-cell communication in luteinized human granulosa cells?SUMMARY ANSWER: BMP2 decreases gap junction intercellular communication (GJIC) of luteinized human granulosa cells by down-regulating Cx43 expression through an activin receptor-like kinase (ALK) 2/ALK3-mediated Sma- and Mad-related protein (SMAD)-dependent signaling pathway.WHAT IS KNOWN ALREADY: BMP2 and its putative receptors are highly expressed in the human corpus luteum and are involved in the process of luteolysis. Cx43-coupled gap junctions play a critical role in the development and maintenance of corpus luteum.STUDY DESIGN DURATION: This is a laboratory study conducted over a 1-year period. At least three independent experiments with three replicates were conducted and the experimental samples were compared with the appropriate vehicle controls for all of the inhibition-approach, concentration-dependent or time-course studies.PARTICIPANTS/MATERIALS, SETTING, METHODS: SVOG cell line (immortalized human granulosa-lutein cells derived from in vitro fertilization patients in an academic research center) was used as the study model. The changes of Cx43 expression and levels of phosphorylated SMAD1/5/8 protein were evaluated after exposure to recombinant human BMP2. Real-time quantitative PCR and Western blot analysis were used to examine the specific mRNA and protein levels, respectively. The BMP/TGF-beta type I receptor inhibitors (Dorsomorphin, DMH-1 and SB431542) and target depletion small interfering RNAs (ALK2, ALK3, ALK6 and SMAD4) were used to investigate the underlying molecular mechanisms. A scrape loading and dye transfer assay was used to evaluate the GJIC between the SVOG cells.MAIN RESULTS AND THE ROLE OF CHANCE: Treatment with BMP2 down-regulated the expression of Cx43 and decreased the GJIC activity, whereas it increased the phosphorylated SMAD1/5/8 protein in SVOG cells (P < 0.05). These biological effects were abolished by pretreatment with the BMP type I receptor inhibitors, Dorsomorphin and DMH-1 (P < 0.05), but not SB431542. Additionally, the individual or concomitant small interfering RNA-mediated knockdown of ALK2 and ALK3, but not ALK6 attenuated the BMP2-induced increases in phosphorylated SMAD1/5/8 and down-regulation of Cx43 expression (P < 0.05). The knockdown of SMAD4 completely abolished the BMP2-induced down-regulation of Cx43 expression (P < 0.05).LIMITATIONS REASONS FOR CAUTION: This experimental study was conducted in an in vitro cell culture system, and may not reflect a realistic intra-ovarian environment.WIDER IMPLICATIONS OF THE FINDINGS: Our results suggested that BMP2 may be involved in the local modulation of cell-cell communication in the luteal phase. This study also represents the first comprehensive research of molecular mechanisms of BMP2 in the down-regulation Cx43 in luteinized human granulosa cells. Such data may provide valuable insights into ovarian physiology and benefit the development of potential therapeutic methods for patients suffering from luteal insufficiency.LARGE SCALE DATA: N/A

Orphan Nuclear Receptor Chicken Ovalbumin Upstream Promoter-Transcription Factor Ii (Coup-Tfii) Protein Negatively Regulates Bone Morphogenetic Protein 2-Induced Osteoblast Differentiation Through Suppressing Runt-Related Gene 2 (runx2) Activity

The orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II is a critical regulator of adipogenesis

Increased COUP-TFII Expression Mediates the Differentiation Imbalance of Bone Marrow-Derived Mesenchymal Stem Cells in Femoral Head Osteonecrosis

Coup D'etat: an Orphan Takes Control

MicroRNA-194 reciprocally stimulates osteogenesis and inhibits adipogenesis via regulating COUP-TFII expression

Two of four alternatively spliced isoforms of RUNX2 control osteocalcin gene expression in human osteoblast cells

Chicken Ovalbumin Upstream Promoter Transcription Factor Ii Regulates The Expression Of Retinoic Acid Receptors And Retinoid X Receptors In Hepatocytes

Runt‐related transcription factor‐2 (Runx2) is required for bone matrix protein gene expression in committed osteoblasts in mice

Parathyroid Hormone Regulates Osterix and Runx2 Mrna Expression Predominantly Through Protein Kinase A Signaling in Osteoblast-Like Cells

RUNX2 co-operates with EGR1 to regulate osteogenic differentiation through Htra1 enhancers.

Inhibition of Runx2 Signaling by TNF-α in ST2 Murine Bone Marrow Stromal Cells Undergoing Osteogenic Differentiation

Runt-related transcription factor 1 is required for murine osteoblast differentiation and bone formation

KLF2 Regulates Osteoblast Differentiation by Targeting of Runx2

Bone Morphogenetic Protein 2 Regulates Cell-Cell Communication by Down-Regulating Connexin43 Expression in Luteinized Human Granulosa Cells

Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation

Opposing TNF-α/IL-1β- and BMP-2-activated MAPK Signaling Pathways Converge on Runx2 to Regulate BMP-2-induced Osteoblastic Differentiation

Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII) regulates growth and patterning of the postnatal mouse cerebellum

Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2

Molecular Mechanism of Runx2-Dependent Bone Development

Foxc2 Over-Expression in Bone Marrow Mesenchymal Stem Cells Stimulates Osteogenic Differentiation and Inhibits Adipogenic Differentiation

Runx1 Up-Regulates Chondrocyte to Osteoblast Lineage Commitment and Promotes Bone Formation by Enhancing Both Chondrogenesis and Osteogenesis.